Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Vultaggio A, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Cameli P, Canonica GW, Caruso C, Centanni S, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Senna G, Benci M, Boarino S, Schroeder JW.
Vultaggio A, et al. Among authors: menzella f.
Respir Res. 2023 May 20;24(1):135. doi: 10.1186/s12931-023-02439-w.
Respir Res. 2023.
PMID: 37210543
Free PMC article.